§483.10(e) Respect and Dignity. The resident has a right to be treated with respect and dignity, including:
§483.10(e)(1) The right to be free from any . . . chemical restraints imposed for purposes of discipline or convenience, and not required to treat the resident's medical symptoms, consistent with §483.12(a)(2).
§483.12 The resident has the right to be free from abuse, neglect, misappropriation of resident property, and exploitation as defined in this subpart. This includes but is not limited to freedom from corporal punishment, involuntary seclusion and any physical or chemical restraint not required to treat the resident's medical symptoms. §483.12(a) The facility must-. . . §483.12(a)(2) Ensure that the resident is free from . . . chemical restraints imposed for purposes of discipline or convenience and that are not required to treat the resident's medical symptoms. . . . . §483.45(c)(3) A psychotropic drug is any drug that affects brain activities associated with mental processes and behavior. These drugs include, but are not limited to, drugs in the following categories: (i) Anti-psychotic; (ii) Anti-depressant; (iii) Anti-anxiety; and (iv) Hypnotic.
§483.45(d) Unnecessary drugs-General. Each resident's drug regimen must be free from unnecessary drugs. An unnecessary drug is any drug when used- (1) In excessive dose (including duplicate drug therapy); or (2) For excessive duration; or (3) Without adequate monitoring; or (4) Without adequate indications for its use; or (5) In the presence of adverse consequences which indicate the dose should be reduced or discontinued; or (6) Any combinations of the reasons stated in paragraphs (d)(1) through (5) of this section.
§483.45(e) Psychotropic Drugs. Based on a comprehensive assessment of a resident, the facility must ensure that--
§483.45(e)(1) Residents who have not used psychotropic drugs are not given these drugs unless the medication is necessary to treat a specific condition as diagnosed and documented in the clinical record;
§483.45(e)(2) Residents who use psychotropic drugs receive gradual dose reductions, and behavioral interventions, unless clinically contraindicated, in an effort to discontinue these drugs;
§483.45(e)(3) Residents do not receive psychotropic drugs pursuant to a PRN order unless that medication is necessary to treat a diagnosed specific condition that is documented in the clinical record; and
§483.45(e)(4) PRN orders for psychotropic drugs are limited to 14 days. Except as provided in §483.45(e)(5), if the attending physician or prescribing practitioner believes that it is appropriate for the PRN order to be extended beyond 14 days, he or she should document their rationale in the resident's medical record and indicate the duration for the PRN order. §483.45(e)(5) PRN orders for anti-psychotic drugs are limited to 14 days and cannot be renewed unless the attending physician or prescribing practitioner evaluates the resident for the appropriateness of that medication.
|
Observations: Based on clinical record review and staff interview, it was determined that the facility failed to ensure that residents were free from chemical restraints for one of five sampled residents who received psychotropic medications. (Resident 1)
Findings include:
Clinical record review revealed that Resident 1 had diagnoses that included anxiety and depression. Review of the Minimum Data Set assessment dated September 10, 2025, revealed that the resident was cognitively impaired and had been administered an anti-anxiety medication. On September 9, 2025, a physician ordered staff to administer an anti-anxiety medication, (lorazepam), every six hours as needed for anxiety. There was no date in the order that indicated when staff was to stop administering the as needed medication. Review of Resident 1's Medication Administration Record revealed that staff had administered the lorazepam on October 4, 7, and 11, 2025. There was no documented evidence that the physician had re-evaluated continued use of the as needed anti-anxiety medication beyond 14 days.
In an interview on October 14, 2025, at 12:53 p.m., the Director of Nursing confirmed that there had been no date added to the order to indicate when staff were to stop administering the anti-anxiety medication.
28 Pa. Code 211.12(d)(1)(5) Nursing services.
| | Plan of Correction - To be completed: 12/05/2025
What corrective action(s) will be accomplished for those residents found to have been affected by the deficient practice? -Resident 1 lorazepam order has a PRN and routine order . The PRN was immediately updated with a stop date.
How will you identify other residents having the potential to be affected by the same deficient practice and what corrective action will be taken?
-The Director of Nursing (DON) or designee will audit all current PRN psychotropic orders and ensure there is a stop date.
What measures will be put into place or what system changes will you make to ensure that the deficient practice does not recur?
-Nursing will review the Point Click Care dashboard every day during work week to evaluate any new orders to ensure they have a stop date.
How the corrective action will be monitored to ensure that the deficient practice will not recur; i.e., what quality assurance programs will be established?
-DON/Designee will complete weekly audits x4 weeks. DON/Designee will report findings to QA and Administrator. The QAPI committee will determine the need for any further audits and/or action plans.
|
|